These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19584439)

  • 21. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.
    Reilly JF; Games D; Rydel RE; Freedman S; Schenk D; Young WG; Morrison JH; Bloom FE
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4837-42. PubMed ID: 12697936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-type calcium channel CaV 1.2 in transgenic mice overexpressing human AbetaPP751 with the London (V717I) and Swedish (K670M/N671L) mutations.
    Willis M; Kaufmann WA; Wietzorrek G; Hutter-Paier B; Moosmang S; Humpel C; Hofmann F; Windisch M; Knaus HG; Marksteiner J
    J Alzheimers Dis; 2010; 20(4):1167-80. PubMed ID: 20413896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astrocytic gap junctional communication is reduced in amyloid-β-treated cultured astrocytes, but not in Alzheimer's disease transgenic mice.
    Cruz NF; Ball KK; Dienel GA
    ASN Neuro; 2010 Aug; 2(4):e00041. PubMed ID: 20730033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease.
    Ceyzériat K; Ben Haim L; Denizot A; Pommier D; Matos M; Guillemaud O; Palomares MA; Abjean L; Petit F; Gipchtein P; Gaillard MC; Guillermier M; Bernier S; Gaudin M; Aurégan G; Joséphine C; Déchamps N; Veran J; Langlais V; Cambon K; Bemelmans AP; Baijer J; Bonvento G; Dhenain M; Deleuze JF; Oliet SHR; Brouillet E; Hantraye P; Carrillo-de Sauvage MA; Olaso R; Panatier A; Escartin C
    Acta Neuropathol Commun; 2018 Oct; 6(1):104. PubMed ID: 30322407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice.
    Sompol P; Furman JL; Pleiss MM; Kraner SD; Artiushin IA; Batten SR; Quintero JE; Simmerman LA; Beckett TL; Lovell MA; Murphy MP; Gerhardt GA; Norris CM
    J Neurosci; 2017 Jun; 37(25):6132-6148. PubMed ID: 28559377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models.
    Norris CM; Kadish I; Blalock EM; Chen KC; Thibault V; Porter NM; Landfield PW; Kraner SD
    J Neurosci; 2005 May; 25(18):4649-58. PubMed ID: 15872113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer's disease.
    Katsouri L; Birch AM; Renziehausen AWJ; Zach C; Aman Y; Steeds H; Bonsu A; Palmer EOC; Mirzaei N; Ries M; Sastre M
    Glia; 2020 May; 68(5):1017-1030. PubMed ID: 31799735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease.
    Portal B; Södergren M; Parés I Borrell T; Giraud R; Metzendorf NG; Hultqvist G; Nilsson P; Lindskog M
    J Alzheimers Dis; 2024; 100(3):1017-1037. PubMed ID: 38995780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuron-astrocyte signaling is preserved in the aging brain.
    Gómez-Gonzalo M; Martin-Fernandez M; Martínez-Murillo R; Mederos S; Hernández-Vivanco A; Jamison S; Fernandez AP; Serrano J; Calero P; Futch HS; Corpas R; Sanfeliu C; Perea G; Araque A
    Glia; 2017 Apr; 65(4):569-580. PubMed ID: 28130845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive astrocytes associated with plaques in TgCRND8 mouse brain and in human Alzheimer brain express phosphoprotein enriched in astrocytes (PEA-15).
    Thomason LA; Smithson LJ; Hazrati LN; McLaurin J; Kawaja MD
    FEBS Lett; 2013 Aug; 587(15):2448-54. PubMed ID: 23792157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High potassium exposure reveals the altered ability of astrocytes to regulate their volume in the aged hippocampus of GFAP/EGFP mice.
    Kolenicova D; Tureckova J; Pukajova B; Harantova L; Kriska J; Kirdajova D; Vorisek I; Kamenicka M; Valihrach L; Androvic P; Kubista M; Vargova L; Anderova M
    Neurobiol Aging; 2020 Feb; 86():162-181. PubMed ID: 31757575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease-associated astrocytes in Alzheimer's disease and aging.
    Habib N; McCabe C; Medina S; Varshavsky M; Kitsberg D; Dvir-Szternfeld R; Green G; Dionne D; Nguyen L; Marshall JL; Chen F; Zhang F; Kaplan T; Regev A; Schwartz M
    Nat Neurosci; 2020 Jun; 23(6):701-706. PubMed ID: 32341542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astrocytes in physiological aging and Alzheimer's disease.
    Rodríguez-Arellano JJ; Parpura V; Zorec R; Verkhratsky A
    Neuroscience; 2016 May; 323():170-82. PubMed ID: 25595973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction.
    Orre M; Kamphuis W; Osborn LM; Jansen AHP; Kooijman L; Bossers K; Hol EM
    Neurobiol Aging; 2014 Dec; 35(12):2746-2760. PubMed ID: 25002035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective tumor necrosis factor-alpha-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease.
    Rossi D; Brambilla L; Valori CF; Crugnola A; Giaccone G; Capobianco R; Mangieri M; Kingston AE; Bloc A; Bezzi P; Volterra A
    J Biol Chem; 2005 Dec; 280(51):42088-96. PubMed ID: 16253995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astrocyte Biomarkers in Alzheimer's Disease.
    Carter SF; Herholz K; Rosa-Neto P; Pellerin L; Nordberg A; Zimmer ER
    Trends Mol Med; 2019 Feb; 25(2):77-95. PubMed ID: 30611668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease.
    Furman JL; Sama DM; Gant JC; Beckett TL; Murphy MP; Bachstetter AD; Van Eldik LJ; Norris CM
    J Neurosci; 2012 Nov; 32(46):16129-40. PubMed ID: 23152597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Astrocytic transporters in Alzheimer's disease.
    Ugbode C; Hu Y; Whalley B; Peers C; Rattray M; Dallas ML
    Biochem J; 2017 Feb; 474(3):333-355. PubMed ID: 28108584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.